AdaptHealth (AHCO) Revenue & Revenue Breakdown
AdaptHealth Revenue Highlights
Latest Revenue (Y)
$3.20B
Latest Revenue (Q)
$805.86M
Main Segment (Y)
Diabetes
Main Geography (Y)
Supplies To Home
AdaptHealth Revenue by Period
AdaptHealth Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $3.20B | 7.73% |
| 2022-12-31 | $2.97B | 21.02% |
| 2021-12-31 | $2.45B | 132.35% |
| 2020-12-31 | $1.06B | 99.45% |
| 2019-12-31 | $529.64M | 53.40% |
| 2018-12-31 | $345.28M | 100.00% |
| 2017-12-31 | - | - |
AdaptHealth generated $3.20B in revenue during NA 2023, up 7.73% compared to the previous quarter, and up 926.84% compared to the same period a year ago.
AdaptHealth Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $805.86M | -0.01% |
| 2024-06-30 | $805.98M | 1.70% |
| 2024-03-31 | $792.50M | -7.66% |
| 2023-12-31 | $858.23M | 6.74% |
| 2023-09-30 | $804.03M | 1.35% |
| 2023-06-30 | $793.29M | 6.53% |
| 2023-03-31 | $744.63M | -4.57% |
| 2022-12-31 | $780.28M | 39.92% |
| 2022-09-30 | $557.65M | -23.36% |
| 2022-06-30 | $727.61M | 3.03% |
| 2022-03-31 | $706.20M | 0.58% |
| 2021-12-31 | $702.11M | 7.47% |
| 2021-09-30 | $653.29M | 5.88% |
| 2021-06-30 | $617.02M | 27.98% |
| 2021-03-31 | $482.12M | 38.37% |
| 2020-12-31 | $348.43M | 22.51% |
| 2020-09-30 | $284.40M | 22.53% |
| 2020-06-30 | $232.12M | 21.25% |
| 2020-03-31 | $191.44M | 28.02% |
| 2019-12-31 | $149.54M | 9.59% |
| 2019-09-30 | $136.45M | 9.90% |
| 2019-06-30 | $124.15M | 3.90% |
| 2019-03-31 | $119.50M | 9.98% |
| 2018-12-31 | $108.65M | 6.36% |
| 2018-09-30 | $102.16M | 51.94% |
| 2018-06-30 | $67.23M | -0.00% |
| 2018-03-31 | $67.23M | - |
AdaptHealth generated $805.86M in revenue during Q3 2024, up -0.01% compared to the previous quarter, and up 101.58% compared to the same period a year ago.
AdaptHealth Revenue Breakdown
AdaptHealth Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 20 |
|---|---|---|---|
| Health Care, Other | $301.15M | $261.62M | - |
| Diabetes | $660.04M | $687.09M | - |
| Supplies To Home | - | - | $145.62M |
AdaptHealth's latest annual revenue breakdown by segment (product or service), as of Dec 23: Diabetes (68.67%), and Health Care, Other (31.33%).
Quarterly Revenue by Product
| Product/Service | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 20 |
|---|---|---|---|---|---|---|
| Health Care, Other | $74.55M | $67.23M | $92.17M | $77.09M | $68.13M | - |
| Supplies To Home | - | - | - | - | - | $45.15M |
AdaptHealth's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Health Care, Other (100.00%).
AdaptHealth Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 20 |
|---|---|
| Supplies To Home | $145.62M |
AdaptHealth's latest annual revenue breakdown by geography, as of Dec 20: Supplies To Home (100.00%).
Quarterly Revenue by Country
| Country | Dec 20 |
|---|---|
| Supplies To Home | $45.15M |
AdaptHealth's latest quarterly revenue breakdown by geography, as of Dec 20: Supplies To Home (100.00%).
AdaptHealth Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AHCO | AdaptHealth | $3.20B | $805.86M |
| ITGR | Integer | $1.60B | $746.27M |
| LIVN | LivaNova | $1.15B | $318.11M |
| AVNS | Avanos Medical | $673.30M | $170.40M |
| AORT | Artivion | $354.00M | $95.78M |
| FNA | Paragon 28 | $216.39M | $61.02M |
| ANIK | Anika Therapeutics | $166.66M | $38.75M |
| AXGN | AxoGen | $159.01M | $48.64M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SRDX | Surmodics | $126.08M | $30.34M |
| SGHT | Sight Sciences | $81.06M | $20.16M |
| LUNG | Pulmonx | $68.67M | $20.39M |
| NPCE | NeuroPace | $65.42M | $21.06M |
| APYX | Apyx Medical | $52.35M | $16.02M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |